Insider · CIK 0001864280
William L. Macias
Files at IMVT (Immunovant, Inc.). First filing Oct 18, 2024, latest Feb 21, 2025.
William L. Macias files SEC Form 4 as officer at IMVT (Immunovant, Inc.). Since Oct 18, 2024, William L. Macias has reported 0 open-market buys worth $0 and 4 open-market sells worth $277k, the latest filed on Feb 21, 2025.
A track record needs three past buys with six months of prices behind them; William L. Macias has 0, so none is measured yet.
The newest scored trade: sold $43k of IMVT on Feb 19, 2025, filed Feb 21, 2025, scored 36 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMVT: Immunovant, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | Immunovant, Inc. | $43k 2,055 shares | -1% | - | |
| 37Weak | Immunovant, Inc. | $57k 2,383 shares | -1% | - | |
| 39Weak | Immunovant, Inc. | $85k 3,353 shares | -1% | - | |
| 39Weak | Immunovant, Inc. | $92k 3,188 shares | -1% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 25, 2025 | IMVT IMMUNOVANT, INC. | 30,000 0.02% of outstanding | $475k | Jun 25, 2025 | $2.2M |
| Jun 13, 2025 | IMVT IMMUNOVANT, INC. | 50,000 0.03% of outstanding | $778k | Jun 13, 2025 | $1.4M |
| Jun 3, 2025 | IMVT IMMUNOVANT, INC. | 80,000 0.05% of outstanding | $1.2M | Jun 3, 2025 | $189k |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,055 | $20.86 | $43k | 357,353 | Feb 21, 2025 |
| Jan 15, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -1,883 | $23.81 | $45k | 359,908 | Jan 17, 2025 |
| Jan 15, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -94 | $24.19 | $2,274 | 359,814 | Jan 17, 2025 |
| Jan 15, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -387 | $23.81 | $9,214 | 359,427 | Jan 17, 2025 |
| Jan 15, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -19 | $24.19 | $460 | 359,408 | Jan 17, 2025 |
| Nov 20, 2024 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -3,353 | $25.45 | $85k | 361,791 | Nov 22, 2024 |
| Oct 16, 2024 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,627 | $28.79 | $76k | 365,705 | Oct 18, 2024 |
| Oct 16, 2024 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -561 | $28.79 | $16k | 365,144 | Oct 18, 2024 |
Questions about William L. Macias
Answered from the filings on this page, as of the latest one.
Is William L. Macias buying or selling?
Not in the last 12 months. William L. Macias's latest open-market trade on SEC Form 4 was sold $43k of IMVT on Feb 19, 2025.
How did William L. Macias's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and William L. Macias has 0.
Where does William L. Macias file Form 4?
William L. Macias has filed Form 4 at IMVT (Immunovant, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.